KRAS and YAP1 Converge to Regulate EMT and Tumor Survival

Shao, Diane D., Xue, Wen, Krall, Elsa B., Bhutkar, Arjun, Piccioni, Federica, Wang, Xiaoxing, Schinzel, Anna C., Sood, Sabina, Rosenbluh, Joseph, Kim, Jong W., Zwang, Yaara, Roberts, Thomas M., Root, David E., Jacks, Tyler, Hahn, William C.·2014·Cell
DOI 10.1016/j.cell.2014.06.004

Cited by (753)

Items 401–500 of 753

  1. MEK inhibition suppresses metastatic progression of KRAS ‐mutated gastric cancer
    Juntaro Yamasaki, Yuki Hirata, Yuji Otsuki, Kentaro Suina, Yoshiyuki Saito, Kenta Masuda, Shogo Okazaki, Takatsugu Ishimoto, Hideyuki Saya, Osamu Nagano · 2021 · Cancer Science
  2. Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer
    Keunwook Lee, Sung Sook Lee, Jun‐Eul Hwang, Hee-Jin Jang, Hyun‐Sung Lee, Sang Cheul Oh, Sang Ho Lee, Bo Hwa Sohn, Sang Bae Kim, Jae‐Jun Shim et al. · 2016 · Clinical Cancer Research
  3. Histone demethylase JMJD1C regulates esophageal cancer proliferation Via YAP1 signaling.
    Yixin Cai, Xiangning Fu, Yu Deng · 2017 · PubMed Central
  4. The G protein–coupled receptor GPR31 promotes membrane association of KRAS
    Nicole Fehrenbacher, Israel Tojal da Silva, Craig Ramírez, Yong Zhou, Kwang-Jin Cho, Shafi Kuchay, Jie Shi, Susan Thomas, Michele Pagano, John F. Hancock et al. · 2017 · The Journal of Cell Biology
  5. Genome-wide DNA methylation analysis of KRAS mutant cell lines
    Ben Yi Tew, Joel K. Durand, Kirsten L. Bryant, Tikvah K. Hayes, Sen Peng, Nhan L. Tran, Gerald C. Gooden, David N. Buckley, Channing J. Der, Albert S. Baldwin et al. · 2020 · Scientific Reports
  6. Retracted: Lovastatin Inhibits RhoA to Suppress Canonical Wnt/β-Catenin Signaling and Alternative Wnt-YAP/TAZ Signaling in Colon Cancer
    Yi Xiao, Qin Liu, Nanyin Peng, Yuzhang Li, Danyang Qiu, Tianlun Yang, Richard D. Kang, Ahsan Usmani, Efosa Amadasu, Cesar V. Borlongan et al. · 2022 · Cell Transplantation · Retracted
  7. Transcriptional Regulation of the Hippo Pathway: Current Understanding and Insights from Single-Cell Technologies
    Sayantanee Paul, Shiqi Xie, Xiaosai Yao, Anwesha Dey · 2022 · Cells
  8. Relationship between gene mutation and lung cancer metastasis
    Rafael Rosell, Niki Karachaliou · 2015 · Cancer and Metastasis Reviews
  9. The genomic landscape of metastasis in treatment-naïve breast cancer models
    Christina R. Ross, Karol Szczepanek, Maxwell Y Lee, Howard Hua Yang, Tinghu Qiu, Jack D. Sanford, Kent W. Hunter · 2020 · PLoS Genetics
  10. YAP Activity is Not Associated with Survival of Uveal Melanoma Patients and Cell Lines
    Yong Joon Kim, Sung Chul Lee, Sung Eun Kim, Sang Kyum Kim, Sang Kyum Kim, Christopher Seungkyu Lee · 2020 · Scientific Reports
  11. Nanostructured Architectures Promote the Mesenchymal–Epithelial Transition for Invasive Cells
    Zongjie Wang, Fan Xia, Mahmoud Labib, Moloud Ahmadi, Haijie Chen, Jagotamoy Das, Sharif Uddin Ahmed, Stéphane Angers, Edward Hartley Sargent, Shana O. Kelley · 2020 · ACS Nano
  12. Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance
    Jianglan Liu, Vito W. Rebecca, Andrew V. Kossenkov, Thomas Connelly, Qin Liu, Alexis Gutierrez, Min Xiao, Ling Li, Gao Zhang, Anastasia Samarkina et al. · 2021 · Cancer Research
  13. Mechanisms of Resistance to KRAS Inhibitors: Cancer Cells' Strategic Use of Normal Cellular Mechanisms to Adapt
    Noritaka Tanaka, Hiromichi Ebi · 2024 · Cancer Science
  14. Changing the course of pancreatic cancer – Focus on recent translational advances
    Milind M. Javle, Talia Golan, Anirban Maitra · 2016 · Cancer Treatment Reviews
  15. miR-1285-3p is a potential prognostic marker in human osteosarcoma and functions as a tumor suppressor by targeting YAP1
    Xiaohui Hu, Jian Dai, Houlai Shang, Zexue Zhao, Yuedong Hao · 2019 · Cancer Biomarkers
  16. The dynamic mechanism of RASSF5 and MST kinase activation by Ras
    Tsung-Jen Liao, Hyunbum Jang, Chung‐Jung Tsai, David Fushman, Ruth Nussinov · 2017 · Physical Chemistry Chemical Physics
  17. Protein arginine methyltransferase 1 coordinates the epithelial-mesenchymal transition/proliferation dichotomy in gastric cancer cells
    Youli Zhang, Dawei Wang, Meiting Zhang, Hong Wei, Ying Lu, Yaocheng Sun, Meng Zhou, Shuming Gu, Wen Feng, Huizhi Wang et al. · 2017 · Experimental Cell Research
  18. TEAD Proteins Associate With DNA Repair Proteins to Facilitate Cellular Recovery From DNA Damage
    Calses, Philamer C., Pham, Victoria C., Guarnaccia, Alissa D., Choi, Meena, Verschueren, Erik, Bakker, Sietske T., Pham, Trang H., Hinkle, Trent, Liu, Chad, Chang, Matthew T. et al. · 2023 · Molecular & Cellular Proteomics
  19. Hippo Signaling Pathway in Colorectal Cancer: Modulation by Various Signals and Therapeutic Potential
    Somayeh Mohammadpour, Amir Torshizi Esfahani, SeyedKasra Sarpash, Fatemeh Vakili, Nikta Zafarjafarzadeh, Amirhesam Mashaollahi, Ali Pardakhtchi, Ehsan Nazemalhosseini Mojarad · 2024 · Analytical Cellular Pathology
  20. Advances in the Genetics and Biology of Pancreatic Cancer
    Andrew J. Aguirre, Eric Andrew Collisson · 2017 · The Cancer Journal
  21. YAP Levels Combined with Plasma CEA Levels Are Prognostic Biomarkers for Early-Clinical-Stage Patients of Colorectal Cancer
    Zihui Xu, Hui Wang, Ling Gao, Hongfeng Zhang, Xiangyang Wang · 2019 · BioMed Research International
  22. Decoding YAP dependent transcription in the liver
    Francesca Biagioni, Ottavio Croci, Silvia Sberna, Elisa Donato, Arianna Sabò, Andrea Bisso, Laura Curti, Arianna Chiesa, Stefano Campaner · 2022 · Nucleic Acids Research
  23. Polyomavirus Small t Antigen Interacts with Yes-Associated Protein To Regulate Cell Survival and Differentiation
    Justin H. Hwang, Arun T. Pores‐Fernando, Nathalie Faure, Shaida Andrabi, William C. Hahn, Brian S. Schaffhausen, Thomas M. Roberts · 2014 · Journal of Virology
  24. Hypoxia induces oncogene yes-associated protein 1 nuclear translocation to promote pancreatic ductal adenocarcinoma invasion via epithelial–mesenchymal transition
    Honglong Wei, Zongzhen Xu, Feng Liu, Fuhai Wang, Xin Wang, Xueying Sun, Jie Li · 2017 · Tumor Biology
  25. Positive regulation of TAZ expression by EBV-LMP1 contributes to cell proliferation and epithelial-mesenchymal transition in nasopharyngeal carcinoma
    Jiang He, Feiyu Tang, Liyu Liu, Lin Chen, Jiang Li, Danming Ou, Lu Zhang, Zhi Li, Deyun Feng, Wenzheng Li et al. · 2016 · Oncotarget
  26. Initiation of human mammary cell tumorigenesis by mutant KRAS requires YAP inactivation
    Sylvain Lefort, Susanna Tan, Sneha Balani, Bo Rafn, Davide Pellacani, Martin Hirst, Poul H. B. Sorensen, Connie J. Eaves · 2019 · Oncogene
  27. The WW domains dictate isoform-specific regulation of YAP1 stability and pancreatic cancer cell malignancy
    Qiang Guo, Meiyu Quan, Jinglai Dong, Jing Bai, Jie Wang, Rui Han, Wei Wang, Yaxin Cai, Yuqing Lv, Qianjie Chen et al. · 2020 · Theranostics
  28. Enhanced Expression of miR-181b in B Cells of CLL Improves the Anti-Tumor Cytotoxic T Cell Response
    Mirco Di Marco, Serena Veschi, Paola Lanuti, Alice Ramassone, Stefania Pacillo, Sara Pagotto, Felice Pepe, Jonahunnatha Nesson George-William, Claudia Curcio, Marco Marchisio et al. · 2021 · Cancers
  29. Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma
    Hiromitsu Hayashi, Norio Uemura, Zhao Liu, Kazuki Matsumura, Hiroki Sato, Yuta Shiraishi, Hideo Andreas Baba · 2021 · Frontiers in Oncology
  30. Direct GDP-KRAS G12C inhibitors and mechanisms of resistance: the tip of the iceberg
    Joshua C. Rosen, Adrian G. Sacher, Ming‐Sound Tsao · 2023 · Therapeutic Advances in Medical Oncology
  31. Cancer lineage-specific regulation of YAP responsive elements revealed through large-scale functional epigenomic screens
    Inês Amorim Monteiro Barbosa, Rajaraman Gopalakrishnan, Samuele Mercan, Thanos P. Mourikis, Typhaine Martin, Simon Wengert, Caibin Sheng, Fei Ji, Rui Lopes, Judith Knehr et al. · 2023 · Nature Communications
  32. Analysis of KRAS , NRAS , PIK3CA , and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer
    Luca Reggiani Bonetti, Valeria Barresi, Stefania Raffaella Bettelli, Cecilia Caprera, Samantha Manfredini, Antonio Maiorana · 2016 · Human Pathology
  33. Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development
    Enrique Rozengurt, Guido Eibl · 2019 · World Journal of Gastroenterology
  34. Prognostic Value of Poorly Differentiated Clusters in Liver Metastatic Lesions of Colorectal Carcinoma
    Keisuke Yonemura, Yoshiki Kajiwara, Tadakazu Ao, Satsuki Mochizuki, Eiji Shinto, Koichi Okamoto, Kazuo Hase, Hideki Ueno · 2019 · The American Journal of Surgical Pathology
  35. YAP1 Takes Over when Oncogenic K-Ras Slumbers
    Florian R. Greten · 2014 · Cell
  36. Norcantharidin reverses cisplatin resistance and inhibits the epithelial mesenchymal transition of human non‑small lung cancer cells by regulating the YAP pathway
    Dan Jin, Yan Wu, Cuijie Shao, Yong Gao, Deqiang Wang, Jiwei Guo · 2018 · Oncology Reports · Retracted
  37. Hippo-YAP signaling in digestive system tumors.
    Feng Yin, Jixin Dong, Liang‐I Kang, Xiuli Liu · 2021 · PubMed Central
  38. Regulation of GTPase function by autophosphorylation
    Christian William Johnson, Hyuk‐Soo Seo, Elizabeth M. Terrell, Moon-Hee Yang, Fenneke KleinJan, Teklab Gebregiworgis, Geneviève M. C. Gasmi-Seabrook, Ezekiel A. Geffken, Jimit Lakhani, Kijun Song et al. · 2022 · Molecular Cell
  39. CXCL12/CXCR7/β-arrestin1 biased signal promotes epithelial-to-mesenchymal transition of colorectal cancer by repressing miRNAs through YAP1 nuclear translocation
    Mahan Si, Yujia Song, Xiaohui Wang, Dong Wang, Xiaohui Liu, Xian‐Jun Qu, Zhiyu Song, Xinfeng Yu · 2022 · Cell & Bioscience
  40. Corepressor metastasis-associated protein 3 modulates epithelial-to-mesenchymal transition and metastasis
    Liang Du, Zhifeng Ning, Fuxing Liu, Hao Zhang · 2017 · 癌症：英文版
  41. EMT induced by loss of LKB1 promotes migration and invasion of liver cancer cells through ZEB1‑induced YAP signaling
    Bijun Qiu, Wei Wei, Jian-wen Zhu, Guangshun Fu, Dahai Lu · 2018 · Oncology Letters
  42. The prognostic value of YAP1 on clinical outcomes in human cancers
    Ying Wu, Yanshen Hou, Peng Xu, Yujiao Deng, Kang Liu, Meng Wang, Tian Tian, Cong Dai, Na Li, Hao Qian et al. · 2019 · Aging
  43. Human telomerase reverse transcriptase is a novel target of Hippo‐YAP pathway
    Qian Zhang, Ning Liu, Junjie Bai, Qi Zhou, Jian Mao, Lu Xu, Jiang Liu, Haibin Wei, Chengcheng Ren, Xiaoying Wu et al. · 2020 · The FASEB Journal
  44. LncRNA-ROR/microRNA-185-3p/YAP1 axis exerts function in biological characteristics of osteosarcoma cells
    Weiguo Wang, Yuezhan Li, Shuang Zhi, Jinsong Li, Jinglei Miao, Zhiyu Ding, Yi Peng, Yan Huang, Ruping Zheng, Haiyang Yu et al. · 2020 · Genomics
  45. Suppression of the HBP Function Increases Pancreatic Cancer Cell Sensitivity to a Pan-RAS Inhibitor
    Francesca Ricciardiello, Laura Bergamaschi, Humberto De Vitto, Gang Yang, Taiping Zhang, Roberta Palorini, Ferdinando Chiaradonna · 2021 · Cells
  46. Ovatodiolide suppresses yes-associated protein 1-modulated cancer stem cell phenotypes in highly malignant hepatocellular carcinoma and sensitizes cancer cells to chemotherapy in vitro
    Hang-Lung Chang, Hsin-An Chen, Oluwaseun Adebayo Bamodu, Kwai-Fong Lee, Yew‐Min Tzeng, Wei‐Hwa Lee, Jo-Ting Tsai · 2018 · Toxicology in Vitro
  47. Mitotic polarization of transcription factors during asymmetric division establishes fate of forming cancer cells
    Yongqing Liu, Laura Siles, Xiaoqin Lu, Kevin C. Dean, Míriam Cuatrecasas, Antonio A. Postigo, Douglas C. Dean · 2018 · Nature Communications
  48. NFAT5 governs cellular plasticity-driven resistance to KRAS-targeted therapy in pancreatic cancer
    Daiyong Deng, Habeebunnisa Begum, Tong Liu, Jiangyan Zhang, Qiang Zhang, Tingyu Chu, Hong Li, Alexander D. Lemenze, Mainul Hoque, Patricia Soteropoulos et al. · 2024 · The Journal of Experimental Medicine
  49. Rottlerin exhibits antitumor activity via down-regulation of TAZ in non-small cell lung cancer
    Zhe Zhao, Nana Zheng, Lixia Wang, Yingying Hou, Xiuxia Zhou, Zhiwei Peter Wang · 2016 · Oncotarget
  50. Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal
    Chai, Tin Fan, Manu, Kanjoormana Aryan, Casey, Patrick J., Wang, Mei · 2020 · Oncogene
  51. CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma
    Toshihiro Morita, Yuzo Kodama, Masahiro Shiokawa, Katsutoshi Kuriyama, Saiko Marui, Takeshi Kuwada, Yuko Sogabe, Tomoaki Matsumori, Nobuyuki Kakiuchi, Teruko Tomono et al. · 2020 · Cancer Research
  52. Anti-Cancer Effects of YAP Inhibitor (CA3) in Combination with Sorafenib against Hepatocellular Carcinoma (HCC) in Patient-Derived Multicellular Tumor Spheroid Models (MCTS)
    Sojung Han, Ji Yeon Lim, Kyungjoo Cho, Hye Won Lee, Jun Yong Park, Simon Weonsang Ro, Kyung Sik Kim, Haeng Ran Seo, Do Young Kim · 2022 · Cancers
  53. Breast Cancer: A Molecular and Redox Snapshot
    Deepika Raman, Chuan Han Jonathan Foo, Marie‐Véronique Clement, Shazib Pervaiz · 2016 · Antioxidants and Redox Signaling
  54. YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma
    Honghai Dai, Yang Washington Shao, Xiaoling Tong, Xue Wu, Jiaohui Pang, Alei Feng, Zhe Yang · 2019 · Cancer Medicine
  55. Independent and core pathways in oncogenic KRAS signaling
    Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang · 2016 · Expert Review of Proteomics
  56. Emerging roles for the YAP/TAZ transcriptional regulators in brain tumour pathology and targeting options
    Dimitrios Strepkos, Mariam Markouli, Kostas A. Papavassiliou, Athanasios G. Papavassiliou, Christina Piperi · 2021 · Neuropathology and Applied Neurobiology
  57. YAP1 and PRDM14 converge to promote cell survival and tumorigenesis
    Mi‐Ju Kim, Seav Huong Ly, Yingtian Xie, Gina N. Duronio, Dane Ford-Roshon, Justin H. Hwang, Rita Sulahian, Jonathan P. Rennhack, Jonathan So, Ole V. Gjoerup et al. · 2022 · Developmental Cell
  58. Mechanical signatures of human colon cancers
    Evelyne Lopez‐Crapez, Luca Costa, Guillaume Tosato, Jeanne Ramos, Thibault Mazard, Janique Guiramand, Alain Roger Thierry, Jacques Colinge, Pierre‐Emmanuel Milhiet, Christine Bénistant · 2022 · Scientific Reports
  59. Mind the (guidance) signals! Translational relevance of semaphorins, plexins, and neuropilins in pancreatic cancer
    Damon Fard, Enrico Giraudo, Luca Tamagnone · 2023 · Trends in Molecular Medicine
  60. The application of CRISPR/Cas9–based genome-wide screening to disease research
    Xiuqin Chen, Min Zheng, Su Lin, Meiqing Huang, Shaoying Chen, Shilong Chen · 2024 · Molecular and Cellular Probes
  61. Altered Transcriptional Control Networks with Trans-Differentiation of Isogenic Mutant-KRas NSCLC Models
    John D. Haley, Elizabeth Haughney, Erica Ullman, James M. Bean, John D. Haley, Marc Y. Fink · 2014 · Frontiers in Oncology
  62. The GSK3β inhibitor BIS I reverts YAP-dependent EMT signature in PDAC cell lines by decreasing SMADs expression level
    Natthakan Thongon, Ilaria Castiglioni, Chiara Zucal, Elisa Latorre, Vito D’Agostino, Inga Bauer, Michael Pancher, Alberto Ballestrero, Georg Feldmann, Alessio Nencioni et al. · 2016 · Oncotarget
  63. Deregulation and Therapeutic Potential of the Hippo Pathway in Cancer
    Kimberly C. Lin, Hyun Woo Park, Kun‐Liang Guan · 2017 · Annual Review of Cancer Biology
  64. Targeted Treatment against Cancer Stem Cells in Colorectal Cancer
    Martínez-Pérez, Julia, Torrado, Carlos, Domínguez-Cejudo, María A., Valladares-Ayerbes, Manuel · 2024 · International Journal of Molecular Sciences
  65. TEAD Inhibitors Sensitize KRASG12C Inhibitors via Dual Cell Cycle Arrest in KRASG12C-Mutant NSCLC
    Tammaccaro, Salvina Laura, Prigent, Philippe, Le Bail, Jean-Christophe, Dos-Santos, Odette, Dassencourt, Laurent, Eskandar, Myriam, Buzy, Armelle, Venier, Olivier, Guillemot, Jean-Claude, Veeranagouda, Yaligara et al. · 2023 · Pharmaceuticals
  66. Emerging insights into lineage plasticity in pancreatic cancer initiation, progression, and therapy resistance
    Xintong Zhang, Yaru Du, Axel Behrens, Linxiang Lan · 2025 · Developmental Cell
  67. Chinese Propolis Suppressed Pancreatic Cancer Panc-1 Cells Proliferation and Migration via Hippo-YAP Pathway
    Lingchen Tao, Xi Chen, Yufei Zheng, Yuqi Wu, Xiasen Jiang, Mengmeng You, Shanshan Li, Fuliang Hu · 2021 · Molecules
  68. MOB3A Bypasses BRAF and RAS Oncogene-Induced Senescence by Engaging the Hippo Pathway
    Kendall Dutchak, Sam Garnett, Mary Nicoll, Angeline de Bruyns, David L. Dankort · 2022 · Molecular Cancer Research
  69. Prediction and validation of GUCA2B as the hub-gene in colorectal cancer based on co-expression network analysis: In-silico and in-vivo study
    Samira Nomiri, Reyhane Hoshyar, Elham Chamani, Zohreh Rezaei, Fatemeh Salmani, Pegah Larki, Tahmine Tavakoli, Faranak Gholipour, Neda Jalili Tabrizi, Afshin Derakhshani et al. · 2022 · Biomedicine & Pharmacotherapy
  70. Identification of Cross Talk between FoxM1 and RASSF1A as a Therapeutic Target of Colon Cancer
    Thomas G. Blanchard, Steven J. Czinn, Vivekjyoti Banerjee, Neha Sharda, Andrea C. Bafford, Fahad Mubariz, Dennis Morozov, Antonino Passaniti, Hafiz Ahmed, Aditi Banerjee · 2019 · Cancers
  71. KRAS-dependent suppression of MYC enhances the sensitivity of cancer cells to cytotoxic agents
    Irene Ischenko, Jizu Zhi, Michael J. Hayman, Oleksi Petrenko · 2017 · Oncotarget
  72. Yap methylation‐induced FGL1 expression suppresses anti‐tumor immunity and promotes tumor progression in KRAS ‐driven lung adenocarcinoma
    Jiang Ji, Pengfei Ye, Ningning Sun, Weihua Zhu, Mei Yang, Manman Yu, Jingjing Yu, Hui Zhang, Zijie Gao, Ningjie Zhang et al. · 2024 · 癌症：英文版
  73. Hippo in Gastric Cancer: From Signalling to Therapy
    Lornella Seeneevassen, Pierre R. Dubus, Caroline Gronnier, Christine Varon · 2022 · Cancers
  74. Development of 42 marker panel for in-depth study of cancer associated fibroblast niches in breast cancer using imaging mass cytometry
    Hanna Røgenes, Kenneth Finne, Ingeborg Winge, Lars A. Akslen, Arne Östman, Vladan Milošević · 2024 · Frontiers in Immunology
  75. Lessons from expanded potential of embryonic stem cells: Moving toward totipotency
    Rongrong Le, Yixin Huang, Anqi Zhao, Shaorong Gao · 2020 · Journal of genetics and genomics/Journal of Genetics and Genomics
  76. Down-regulated Solute Carrier Family 4 Member 4 Predicts Poor Progression in Colorectal Cancer
    Hong Yang, Yao Lu, Weilan Lan, Bin Huang, Jiumao Lin · 2020 · Journal of Cancer
  77. p190A RhoGAP induces CDH1 expression and cooperates with E-cadherin to activate LATS kinases and suppress tumor cell growth
    Hanyue Ouyang, Phi Luong, Morten Frödin, Steen H. Hansen · 2020 · Oncogene
  78. “Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines”
    Luca Sanna, Roberta Piredda, Irene Marchesi, Valentina Bordoni, Sonia Vanina Forcales, Diego Francesco Calvisi, Luigi Bagella · 2019 · Chemico-Biological Interactions
  79. YAP1 Promotes Tumor Invasion and Metastasis in Nasopharyngeal Carcinoma with Hepatitis B Virus Infection
    Zeli Huang, Bojin Su, Fang Liu, Ning Zhang, Yilong Ye, Yang Zhang, Zhenghe Zhen, Shaoqiang Liang, Shaobo Liang, Lushi Chen et al. · 2020 · OncoTargets and Therapy
  80. Conquering oncogenic KRAS and its bypass mechanisms
    Pingping Hou, Yanru Wang · 2022 · Theranostics
  81. Histone Modifications Represent a Key Epigenetic Feature of Epithelial-to-Mesenchyme Transition in Pancreatic Cancer
    Ying Xin Xu, Qing Zhu · 2023 · International Journal of Molecular Sciences
  82. Corosolic acid inhibits EMT in lung cancer cells by promoting YAP-mediated ferroptosis
    Congcong Zhang, Lingli Gao, Yinghui Zhang, Xiaoqin Jin, Mengyu Wang, Qianna Wang, Wenyu Zhao, Nan Wu, Yasu Zhang, Yaru Liu et al. · 2024 · Phytomedicine
  83. Pharmacological strategies to target oncogenic KRAS signaling in pancreatic cancer
    Hsiao-Ching Chuang, Po-Hsien Huang, Samuel Kiyota Kulp, Ching‐Shih Chen · 2017 · Pharmacological Research
  84. Role and regulation of Yap in KrasG12D-induced lung cancer
    Yaopan Mao, Shuguo Sun, Kenneth D. Irvine · 2017 · Oncotarget
  85. Pseudolaric Acid B Inhibits Proliferation, Invasion and Epithelial-to-Mesenchymal Transition in Human Pancreatic Cancer Cell
    Xiaoyu Li, Xianzhi Zhao, Wen Song, Zibin Tian, Lin Yang, Qinghui Niu, Qi Zhang, Man Xie, Bin Zhou, Yonghong Xu et al. · 2017 · Yonsei Medical Journal
  86. Genotype-Fitness Maps of EGFR-Mutant Lung Adenocarcinoma Chart the Evolutionary Landscape of Resistance for Combination Therapy Optimization
    Patrick O. Bolan, Asaf Zviran, Lisa Brenan, Joshua S. Schiffman, Neville N. Dusaj, Amy B. Goodale, Federica Piccioni, Cory M. Johannessen, Dan Avi Landau · 2019 · Cell Systems
  87. KRAS-G12C covalent inhibitors: A game changer in the scene of cancer therapies
    Nabih Naim, Sara Moukheiber, Samah Daou, Hampig Raphaël Kourié · 2021 · Critical Reviews in Oncology/Hematology
  88. Functions of Yes-association protein (YAP) in cancer progression and anticancer therapy resistance
    Yu Zhang, Xiang Wang, Xiuping Zhou · 2022 · Brain Science Advances
  89. Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools
    Akbar Hasanzadeh, Arefeh Ebadati, Lida Dastanpour, Amir Reza Aref, Parham Sahandi Zangabad, Alireza Kalbasi, Xiaofeng Dai, Geeta Mehta, Amir Ghasemi, Yousef Fatahi et al. · 2023 · ACS Pharmacology & Translational Science
  90. lncRNA KCNQ1OT1 promotes proliferation and invasion of glioma cells by targeting the miR‑375/YAP pathway
    Panfeng Ding, Bo Liang, Jixin Shou, Xinjun Wang · 2020 · International Journal of Molecular Medicine · Retracted
  91. Transcription factor Sp1 is upregulated by PKCι to drive the expression of YAP1 during pancreatic carcinogenesis
    Jinhe Yang, Junli Wang, Hongmei Zhang, Chang Long Li, Changyan Chen, Tongbo Zhu · 2020 · Carcinogenesis
  92. Clinical significance of YAP1 and TAZ in esophageal squamous cell carcinoma
    Li Liu, Ziyang Lu, Xiayun Hu, Tianyuan Su, Liping Su, Hongwei Pu · 2021 · Medicine
  93. Models of pancreatic ductal adenocarcinoma
    Rayane Dennaoui, Hridaya Shrestha, Kay‐Uwe Wagner · 2021 · Cancer and Metastasis Reviews
  94. Capicua Suppresses YAP1 To Limit Tumorigenesis and Maintain Drug Sensitivity in Human Cancer
    Ji Won Kim, Cuyler Luck, Wei Wu, Rovingaile Kriska Ponce, Yone Kawe Lin, Nehal Gupta, Ross A. Okimoto · 2021 · Cell Reports
  95. Clinicopathological examination of dipeptidase�1 expression in colorectal cancer
    Kazunoshin Tachibana, Motonobu Saito, Jun‑Ichi Imai, Emi Ito, Yuka Yanagisawa, Reiko Honma, Katsuharu Saito, Jin Ando, Tomoyuki Momma, Shinji Ohki et al. · 2017 · Biomedical Reports
  96. KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplex
    Donald D. Rao, Xiuquan Luo, Zhaohui Wang, Christopher M. Jay, Francis Charles Brunicardi, William A. Maltese, Luisa Manning, Neil N. Senzer, John J. Nemunaitis · 2018 · PLoS ONE
  97. Mu‐KRAS attenuates Hippo signaling pathway through PKCι to sustain the growth of pancreatic cancer
    Peipei Wang, Hongmei Zhang, Jinhe Yang, Zongxian Li, Yiren Wang, Xiaohong Leng, Suthakar Ganapathy, Pauline Isakson, Changyan Chen, Tongbo Zhu · 2019 · Journal of Cellular Physiology
  98. MicroRNA‑15a‑5p‑targeting oncogene YAP1 inhibits cell viability and induces cell apoptosis in cervical cancer cells
    Xu Chen, Ruiqin Cao, Haifang Liu, Tuanying Zhang, Xinrong Yuan, Shuxiang Xu · 2020 · International Journal of Molecular Medicine · Retracted
  99. Regorafenib inhibits epithelial-mesenchymal transition and suppresses cholangiocarcinoma metastasis via YAP1-AREG axis
    Yu‐Chan Chang, Chien‐Hsiu Li, Ming‐Hsien Chan, Ming‐Huang Chen, Chun‐Nan Yeh, Michael Hsiao · 2022 · Cell Death and Disease
  100. Drivers of cancer metastasis – Arise early and remain present
    Dagmara Dymerska, Anna A. Marusiak · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer